First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
First patients dosed in OPTIMAL-e[1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier prostate cancer treatment setting, building on the...
PartnerOne Launches a Global Philanthropic Initiative to Expand Pediatric Surgical Care in Developing Countries
PartnerOne Global Surgery (POGS) begins with a $10 million commitment from PartnerOne and an inaugural partnership with Montreal Children's Hospital, one of the most renowned pediatric hospitals in the world. RIVERSIDE, Calif., May 19, 2026...
iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System
ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc., creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Nabsys and Hitachi Present Electronic Genome Mapping Data at Japanese Society of Human Genetics (JSHG) 2025 Annual Meeting
TOKYO, Dec. 18, 2025 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, in partnership with Hitachi High-Tech Corporation (HHT) announces the presentation of high resolution structural variation data on the...
The 42nd Sandy Bay Charity Fair: Celebrating 70 Years of Transforming Lives by The Society for the Relief of Disabled Children (SRDC) and The Duchess of Kent Children's Hospital
HONG KONG, Nov. 18, 2025 /PRNewswire/ -- The Society for the Relief of Disabled Children (SRDC), one of Hong Kong's longest-standing non-profit organisations, is proud to announce the 42nd Sandy Bay Charity Fair at The Duchess of Kent Children's...
LSBF Singapore Shines at HR Excellence Awards 2025
SINGAPORE, Nov. 4, 2025 /PRNewswire/ -- The London School of Business and Finance (LSBF) Singapore Campus has been honoured at the HR Excellence Awards Singapore 2025, a recognition that celebrates its commitment to people-first leadership and...
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'
YONGIN, South Korea, Nov. 3, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been...
The Society for the Relief of Disabled Children in Hong Kong Celebrates 70 Years Founded Transforming Lives
Striving for HK$5 million Donations to Help "Bring The Children Home" Campaign and Other Impactful Programmes for Children with Special Needs HONG KONG, Oct. 22, 2025 /PRNewswire/ -- The Society for the Relief of Disabled Children (SRDC), one of the...
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
TAIPEI and SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological...
Innovation and Collaboration: Advancing China's Blood Purification Industry
LIUYANG, China, April 19, 2025 /PRNewswire/ -- On April 19, 2025, the Blood Purification Professional Committee (BPPC) of the China Medical Device Industry Association (CMDIA) gathered in Liuyang, Hunan, for its annual conference, themed "Synergy...